CCBT Chatbots for Phobia Treatment

Phobias · Andreas Grivas, MSc Clinical Psychologist · April 10, 2023

CCBT Chatbots for Phobia Treatment

A specific phobia is an intense, persistent fear of a particular object or situation, such as heights, spiders, flying, needles or enclosed spaces, that is out of proportion to the real danger. Most people with a phobia know that their fear is excessive, yet the anxiety is hard to override, so they gradually organise their lives around avoiding the trigger. Avoidance brings quick relief, but it also prevents the person from discovering that the situation is manageable, and this keeps the fear alive. Over time a phobia can quietly limit travel, career choices, medical care and social life.

Cognitive-Behavioural Therapy (CBT) treats phobias mainly through exposure. Together with the therapist, the person builds a hierarchy of feared situations and approaches them step by step, staying in each situation long enough to test catastrophic predictions («the ladder will collapse», «I will lose control») and gradually dropping safety behaviours such as gripping a rail or looking away. Cognitive work helps to name and question these predictions, while exposure provides the direct experience that changes them. Exposure in real life (in vivo) is regarded as the gold standard (Wechsler et al., 2019), and it can sometimes be delivered in a single extended session. The problem is access: few clinicians are trained in it, and arranging real exposure to heights, flights or animals takes time and logistics.

This is where digital tools enter. The word «chatbot» is used broadly here to mean a conversational agent that guides the user through text, voice or an animated avatar. In the phobia field, the strongest evidence does not yet come from text-only chatbots but from automated programmes in which a virtual coach leads the person through exposure. In a randomised controlled trial with 100 adults with a fear of heights, an automated virtual reality (VR) treatment guided by an avatar coach, delivered in roughly six 30-minute sessions over two weeks, produced a large reduction in fear compared with usual care, with a Cohen's d of 2.0 (Freeman et al., 2018).

Similar results have been reported with simpler technology. In a trial with 193 adults with acrophobia, a fully self-guided smartphone app with six animated modules and low-cost cardboard VR goggles, used at home over three weeks, led to large symptom reductions compared with a waiting list, and the gains were still present at the three-month follow-up (Donker et al., 2019). For spider phobia, a single session of automated VR exposure, run with a technician present, was compared with the classic in-vivo one-session treatment in 100 participants. Both groups improved substantially; the VR treatment was initially less effective, but it was non-inferior to in-vivo exposure at the three- and twelve-month follow-ups (Miloff et al., 2019).

The wider meta-analytic picture is encouraging but more nuanced. A meta-analysis of 30 randomised trials with 1,057 participants found a large effect of VR exposure compared with waiting lists (g = 0.90) and no significant difference compared with in-vivo exposure; however, larger studies tended to report smaller effects (Carl et al., 2019). A review restricted to trials that matched the amount of exposure found a small, non-significant difference favouring in-vivo exposure for specific phobia, while for social phobia real-life exposure was clearly superior (Wechsler et al., 2019). For text-based chatbots, the evidence is thinner: a systematic review of 12 studies found only weak evidence that chatbots improve outcomes such as acrophobia, along with a high risk of bias in the included studies (Abd-Alrazaq et al., 2020). A more recent meta-analysis of AI-based conversational agents showed reductions in depression (g = 0.64) and psychological distress (g = 0.70), but it does not allow firm conclusions about phobias specifically (Li et al., 2023). For now, the most credible role for a chatbot is as a guide: explaining how fear works, helping the user build a fear hierarchy, prompting and encouraging real-world exposure practice and tracking progress, rather than acting as a proven stand-alone treatment.

The limitations matter. Many trials are small and short, use waiting-list control groups and recruit motivated volunteers through advertisements, and most focus on a few phobias, mainly heights and spiders. It is unclear how well the results apply to fear of flying, blood-injection-injury phobia or to people with several problems at once. Avoidance is the core of a phobia, so the same tendency can lead users to skip the hardest exercises or abandon an app. Chatbots can misunderstand what a user writes and are not designed to manage emergencies, and VR can cause dizziness or nausea in some people. Digital self-help is generally not suitable when the fear is part of a broader condition such as panic disorder, agoraphobia or PTSD, when there is significant depression, thoughts of self-harm or substance misuse, or when intense anxiety could be medically risky, for example in people with heart disease or a history of fainting at the sight of blood or needles; in these cases a doctor or clinician should be consulted first. Children and adolescents need the involvement of parents and professionals.

It is worth seeking a qualified clinician if the fear causes marked distress or restricts your daily life, if you are avoiding necessary medical or dental care, if self-guided attempts have stalled, or if the phobia is accompanied by panic attacks, low mood or other symptoms. Therapist-led exposure for specific phobias is often brief and highly effective, and a clinician can adapt it safely to your health and circumstances. If you are ever in crisis or having thoughts of harming yourself, contact your local emergency number immediately. Digital tools can complement this work, but they do not replace professional assessment and care.

In summary, automated, coach-guided exposure, especially in VR, has produced impressive results for some specific phobias, and conversational agents may make exposure-based CBT more accessible and easier to practise between sessions. The evidence for text-only chatbots in phobia treatment, however, is still limited. Used thoughtfully, and with professional support when needed, these tools can help more people take the first step towards facing what they fear.

References

  • Abd-Alrazaq, A. A., Rababeh, A., Alajlani, M., Bewick, B. M., & Househ, M. (2020). Effectiveness and safety of using chatbots to improve mental health: Systematic review and meta-analysis. Journal of Medical Internet Research, 22(7), e16021. https://doi.org/10.2196/16021
  • Carl, E., Stein, A. T., Levihn-Coon, A., Pogue, J. R., Rothbaum, B., Emmelkamp, P., Asmundson, G. J. G., Carlbring, P., & Powers, M. B. (2019). Virtual reality exposure therapy for anxiety and related disorders: A meta-analysis of randomized controlled trials. Journal of Anxiety Disorders, 61, 27–36. https://doi.org/10.1016/j.janxdis.2018.08.003
  • Donker, T., Cornelisz, I., van Klaveren, C., van Straten, A., Carlbring, P., Cuijpers, P., & van Gelder, J.-L. (2019). Effectiveness of self-guided app-based virtual reality cognitive behavior therapy for acrophobia: A randomized clinical trial. JAMA Psychiatry, 76(7), 682–690. https://doi.org/10.1001/jamapsychiatry.2019.0219
  • Freeman, D., Haselton, P., Freeman, J., Spanlang, B., Kishore, S., Albery, E., Denne, M., Brown, P., Slater, M., & Nickless, A. (2018). Automated psychological therapy using immersive virtual reality for treatment of fear of heights: A single-blind, parallel-group, randomised controlled trial. The Lancet Psychiatry, 5(8), 625–632. https://doi.org/10.1016/S2215-0366(18)30226-8
  • Li, H., Zhang, R., Lee, Y.-C., Kraut, R. E., & Mohr, D. C. (2023). Systematic review and meta-analysis of AI-based conversational agents for promoting mental health and well-being. npj Digital Medicine, 6, Article 236. https://doi.org/10.1038/s41746-023-00979-5
  • Miloff, A., Lindner, P., Dafgård, P., Deak, S., Garke, M., Hamilton, W., Heinsoo, J., Kristoffersson, G., Rafi, J., Sindemark, K., Sjölund, J., Zenger, M., Reuterskiöld, L., Andersson, G., & Carlbring, P. (2019). Automated virtual reality exposure therapy for spider phobia vs. in-vivo one-session treatment: A randomized non-inferiority trial. Behaviour Research and Therapy, 118, 130–140. https://doi.org/10.1016/j.brat.2019.04.004
  • Wechsler, T. F., Kümpers, F., & Mühlberger, A. (2019). Inferiority or even superiority of virtual reality exposure therapy in phobias?—A systematic review and quantitative meta-analysis on randomized controlled trials specifically comparing the efficacy of virtual reality exposure to gold standard in vivo exposure in agoraphobia, specific phobia, and social phobia. Frontiers in Psychology, 10, Article 1758. https://doi.org/10.3389/fpsyg.2019.01758